WINT
Windtree Therapeutics Inc /De/Company with tickers: WINT
CIK
946486
CUSIP
97382D600
Shares Outstanding
33,708,784
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $19,882,000 | USD | 2025-09-30 | 10-Q | 2025-11-19 |
| Research & Development | $1,897,000 | USD | 2025-09-30 | 10-Q | 2025-11-19 |
| Operating Income | $-19,882,000 | USD | 2025-09-30 | 10-Q | 2025-11-19 |
| Net Income | $-28,085,000 | USD | 2025-09-30 | 10-Q | 2025-11-19 |
| EPS (Basic) | $-1.08 | USD/shares | 2025-09-30 | 10-Q | 2025-11-19 |
| EPS (Diluted) | — |